Author Details

Горбунова, В. А

Issue Section Title File
No 1s (2012) Articles SORAFENIB V LEChENII RASPROSTRANENNOGO GEPATOTsELLYuLYaRNOGO RAKA
No 18 (2012) Articles Own experience of use of EGFR tyrosine kinase inhibitors and bevacizumab in the treatment of patients with non-small cell lung cancer
No 18 (2012) Articles Herceptin in the treatment of disseminated HER2-positive gastric cancer. Clinical case of successful treatment of elderly patient
No 8 (2014) Articles NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
No 8 (2014) Articles EVEROLIMUS (AFINITOR): NOVYE VOZMOZhNOSTI TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
No 8 (2015) Articles Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
No 8 (2016) Articles NEW POTENTIALS FOR THE USE OF SOMATOSTATIN ANALOGS IN NEUROENDOCRINE TUMORS
No 17 (2016) Articles THE USE OF SUNITINIB IN PANCREATIC NEUROENDOCRINE TUMORS: EXPERIENCE OF THE DEPARTMENT OF CHEMOTHERAPY FSBI RORC N.A. N.N. BLOKHIN OF RMH
No 8 (2017) Articles Cashuistic case of treatment of discemned small-cell lung cancer
No 8 (2017) Articles Combined targeted therapy with dabraphenib +trametinib in treatment of melanoma patients with V600 BRAF mutations and brain metastases
No 17 (2017) Articles Example of the integrated approach to treatment of the patient with disseminated stomach cancer taking into account of modern clinical trends
No 7 (2018) Articles RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
No 12 (2018) Articles Neuroendocrine tumors: general characteristics and features of management tactics
No 12 (2018) Articles Pharmacotherapy of neuroendocrine tumors
Vol 26, No 12 (2019) Articles Neuroendocrine tumors: current changes in the classification, diagnosis and therapy presented in the draft clinical guidelines of the Ministry of Health of the Russian Federation 2019

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies